Okay — it’s not exactly a milkshake. Wendy’s signature Frosty is a unique treat concocted by founder Dave Thomas himself. Signature menu items like the… Read More »AI-Powered Milkshakes And The Future Of Fast Food

I’m sure you have noticed that since the election swung in favor of the former president (who happens to be a business mogul), the stock… Read More »10 Times The Stock Market Acted Like A Rollercoaster (And Why)

Comparative analysis is simply finding the similarities or differences between two or more things. I did this a lot when I was a journalist. After… Read More »A Once-In-A-Century Election Market Rally

There’s a small group of investors that control a whole lot of money that are still on edge and planning for a situation that most… Read More »The Bond Market Is Screaming… Take These Three Actions Immediately

I need you to hear me loud and clear when I tell you: These next two years will be the most important in your life… Read More »Post-Election Report: We’re FULL STEAM AHEAD For 2025

The global semiconductor industry is witnessing a strong recovery phase after sales suffered in 2023. The rebound is being fueled by advancements in artificial intelligence… Read More »3 Semiconductor Stocks With Room To Run

Half the country is happy, and half the country is sad, that’s the way democracy goes sometimes. This is a financial publication, so we are… Read More »3 Stocks Poised To Benefit From A Trump Presidency

The Tech Demand Indicator (TDI) measures the intent of businesses to spend money on technology. More importantly, it breaks down what specific technology businesses have… Read More »Is AI Losing Its Luster?

While the debate over whether it’s better to pay for high-quality or high-growth businesses will never end, the easiest solution is to find stocks offering… Read More »This Stock Is Offering A Once-In-A-Decade Opportunity

We’ve seen a radical evolution in the types of medication and available diagnostics for treating different diseases. This really came to a head back in… Read More »The State Of Biotech After A Rocky 2024